Pour en savoir plus by Société Française de Sénologie et Pathologie mammaire (SFSPM)
Pour en savoir plus…
L’épaule après cancer du sein
Levy EW, Pfalzer LA, Danoff  J (2012) Predictors of functional shoulder 
recovery at 1 and 12 months after breast cancer surgery. Breast Cancer Res 
Treat 134: 315-24
Th e objective of this study are (1) to determine if upper extremity function, as 
represented by shoulder ROM, self-reported symptoms and upper extremity 
functional limitations in activities of daily living could be predictively related 
to demographic and cancer characteristics post-surgery for breast cancer. And 
(2) to examine if variables related to early onset impairment contribute to late 
onset impairments in women after breast cancer surgery. Subjects were assessed 
preoperatively and 1, 3, 6, 9, and 12+ months post breast cancer surgery for 
impairments and symptoms and at 12+ months for shoulder functional limita-
tions using a physical therapy surveillance model. Body weight, shoulder ROM, 
manual muscle testing, and upper limb volume were recorded. At 12+ months, 
the Harvard Alumni Health Study Physical Activity Questionnaire, and an Upper 
Limb Disability Questionnaire were administered. Symptoms and ROM impair-
ments were compared by functional limitations. Characteristics signifi cantly 
associated with early ROM impairment (but not later impairment) were axillary 
lymph node dissection, removal of ≥15 nodes, mastectomy surgery and stage II 
breast cancer. Positive nodes, older age, and BMI ≥ 25 were signifi cantly asso-
ciated with reduced shoulder ROM at 12+ months. At 12+ months, only 10 % 
of the patients experienced ROM impairments while rates of self-reported symp-
toms in the aff ected upper extremity at 12+ months were as follows: pain-49 %, 
weakness-47.1 %, numbness-55.9 %, feeling tired-42.5 %. Th e majority of 
patients used the aff ected upper extremity for reaching without limitation, but 
≥35 % reported limitation with household chores, carrying and lifting. Diffi  culty 
carrying and lifting could be predicted by BMI ≥ 25 and use of the dominant 
aff ected upper limb. Diff erent factors are associated with early versus later ROM 
loss. Symptoms reported by breast cancer survivors are frequently associated with 
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functional limitations in upper extremity tasks and warrant intervention. Physical 
therapy using a prospective surveillance model of care may reduce severity of 
ROM loss, symptoms and functional upper extremity limitations 1 year after 
breast cancer surgery.
Binkley JM, Harris SR, Levangie PK (2012) Patient perspectives on breast 
cancer treatment side eff ects and the prospective surveillance model for 
physical rehabilitation for women with breast cancer. Cancer 118 (8 Suppl): 
2207-16
Women’s experience of breast cancer is complex, aff ecting all aspects of life during 
and after treatment. Patients’ perspectives about common impairments and func-
tional limitations secondary to breast cancer treatment, including upper extremity 
motion restriction, lymphedema, fatigue, weight gain, pain, and chemotherapy-
induced peripheral neuropathy, are addressed. Women often report being unin-
formed regarding these side eff ects and surprised that they do not always disappear 
after treatment, but remain part of their lives. Breast cancer patients express strong, 
unmet needs for education, information, and intervention for these side eff ects. 
Evidence suggests that rehabilitation and exercise are eff ective in preventing and 
managing many physical side eff ects of breast cancer treatment. Nevertheless, few 
women are referred to rehabilitation during or after treatment, and fewer receive 
baseline assessments of impairment and function to facilitate early detection of 
impairment and functional limitations. Th e prospective surveillance model of reha-
bilitation will serve the needs of women with breast cancer by providing education 
and information about treatment side eff ects, reducing the incidence and burden 
of side eff ects through early identifi cation and treatment, and enhancing access to 
timely rehabilitation. Integration of exercise as a component of the model benefi ts 
patients at every phase of survivorship, by addressing individual concerns about 
exercise during and after treatment and highlighting the important contribution 
of exercise to overall health and survival. Th e prospective surveillance model of 
rehabilitation can meet the evident and often expressed needs of survivors for infor-
mation, guidance, and intervention--thus addressing, and potentially improving, 
overall quality of life for individuals diagnosed with and treated for breast cancer.
Hayes SC, Johansson K, Stout NL (2012) Upper-body morbidity after breast 
cancer: incidence and evidence for evaluation, prevention, and management 
within a prospective surveillance model of care. Cancer 118 (8 Suppl): 2237-49
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Th e purpose of this paper is to review the incidence of upper-body morbidity (arm 
and breast symptoms, impairments, and lymphedema), methods for diagnosis, 
and prevention and treatment strategies. It was also the purpose to highlight the 
evidence base for integration of prospective surveillance for upper-body morbidity 
within standard clinical care of women with breast cancer. Between 10% and 
64% of women report upper-body symptoms between 6 months and 3 years after 
breast cancer, and approximately 20% develop lymphedema. Symptoms remain 
common into longer-term survivorship, and although lymphedema may be tran-
sient for some, those who present with mild lymphedema are at increased risk 
of developing moderate to severe lymphedema. Th e etiology of morbidity seems 
to be multifactorial, with the most consistent risk factors being those associated 
with extent of treatment. However, known risk factors cannot reliably distinguish 
between those who will and will not develop upper-body morbidity. Upper-
body morbidity may be treatable with physical therapy. Th ere is also evidence 
in support of integrating regular surveillance for upper-body morbidity into the 
routine care provided to women with breast cancer, with early diagnosis poten-
tially contributing to more eff ective management and prevention of progression 
of these conditions.
Sport et témoignages
Harris SR (2012) «We’re All in the Same Boat»: A Review of the Benefi ts 
of Dragon Boat Racing for Women Living with Breast Cancer. Evid Based 
Complement Alternat Med 2012: 167651
Th is narrative review summarizes fi ndings from quantitative and qualitative 
research literature that has been published over the past 15 years since an initial, 
community-based pilot study fi rst challenged the long-held medical belief that 
vigorous, upper-body exercise would lead to lymphedema in women who were 
at risk due to treatments for breast cancer. Dragon boat racing originated in 
China more than 2000 years ago and has become a popular recreational and 
competitive support around the world. From the advent of the world’s fi rst breast 
cancer survivor dragon boat team, Abreast in a Boat launched in Vancouver, 
British Columbia, in 1996, there are now more than 140 breast cancer survivor 
dragon boat teams paddling and competing in 12 diff erent countries. Th e wealth 
of quantitative and qualitative research that has ensued since that pilot study 
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further supports the initial hypothesis that resistance exercise, for example, 
dragon boat paddling, is not only safe for women recovering from conventional 
breast cancer therapies but also shows that dragon boating has been embraced 
as a complementary exercise therapy by the cancer survivors participating in 
this magical sport
Lymphœdème
Rodríguez-Bujaldón A, Vázquez-Bayo MC, Galán-Gutiérrez M (2006) 
Angiosarcoma in chronic lymphedema. Actas Dermosifi liogr 97: 525-8
Angiosarcoma that develops on a limb with chronic lymphedema is called Stewart-
Treves syndrome. Th is typically appears as a complication of a long course lymphe-
dema located on the arm, after mastectomy and/or radiotherapy due to breast 
cancer. Th ere are cases of Stewart-Treves syndrome in chronic lymphedema in the 
upper limb contralateral to the breast treated for cancer and in chronic lymphe-
dema of the leg. We present two cases of this syndrome. Th e fi rst corresponds to a 
typical syndrome of Stewart-Treves in an 83-year-old woman who was diagnosed 
of angiosarcoma in a chronic lymphedema territory secondary to mastectomy 
and radiotherapy due to breast cancer. Th e second case is much rarer, since it 
is a case of diff use angiosarcoma of the leg in a 42-year-old man with a history 
of lymphedema. Due to the aggressive nature of this syndrome, knowledge and 
research on its treatment are necessary
Kopec JA, Colangelo LH, Land SR et al. (2012) Relationship Between Arm 
Morbidity and Patient-Reported Outcomes Following Surgery in Women 
with Node-Negative Breast Cancer: NSABP Protocol B-32. J Support Oncol 
[Epub ahead of print]
Th e impact of arm morbidity following breast cancer surgery on patient-observed 
changes in daily functioning and health-related quality of life (HRQoL) has not 
been well-studied.
To examine the association of objective measures such as range of motion 
(ROM) and lymphedema, with patient-reported outcomes (PROs) in the arm 
and breast, upper extremity function, activities, and HRQoL.
Th e National Surgical Adjuvant Breast and Bowel Project Protocol B-32 was a 
randomized trial comparing sentinel node resection (SNR) with axillary dissection 
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(AD) in women with node-negative breast cancer. ROM and arm volume were 
measured objectively. PROs included symptoms; arm function; limitations in 
social, recreational, occupational, and other regular activities; and a global index 
of HRQoL. Statistical methods included cross-tabulations and multivariable 
linear regression models.
In all, 744 women provided at least 1 postsurgery assessment. About one-
third of the patients experienced arm mobility restrictions. A similar number of 
patients avoided the use of the arm 6 months after surgery. Limitations in work 
and other regular activities were reported by about a quarter of the patients. In 
this multivariable analysis, arm mobility and sensory neuropathy were predictors 
of patient-reported arm function and overall HRQoL. Predictors for activity 
limitations also included side of surgery (dominant vs nondominant). Edema 
was not signifi cant after adjustment for sensory neuropathy and ROM.
Arm mobility and edema were measured simultaneously only once during 
the follow-up (6 months).
Clinical measures of sensory neuropathy and restrictions in arm mobility 
following breast cancer surgery are associated with self-reported limitations in 
activity and reductions in overall HRQoL.
Kwan ML, Shen L, Munneke JR et al. (2012) Patient awareness and know-
ledge of breast cancer-related lymphedema in a large, integrated health care 
delivery system. Breast Cancer Res Treat 135: 591-602
Breast cancer patients have voiced dissatisfaction regarding their education on 
breast cancer-related lymphedema risk and risk reduction strategies from their 
clinicians. Informing patients about lymphedema can contribute to decrease 
their risk of developing the condition, or among those already aff ected, prevent 
it from progressing further. In this cross-sectional study, a lymphedema awareness 
score was calculated based on responses to a brief telephone interview conducted 
among 389 women diagnosed with invasive breast cancer at Kaiser Permanente 
Northern California from 2000 to 2008 and had a previous record of a lymphe-
dema-related diagnosis or procedure in their electronic medical record. During 
the telephone interview, women self-reported a lymphedema clinical diagnosis, 
lymphedema symptoms but no lymphedema diagnosis, or neither a diagnosis nor 
symptoms, and responded to questions on lymphedema education and support 
services as well as health knowledge. Multivariable logistic regression [odds ratio 
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(OR) and 95 % confi dence interval (CI)] was used to determine the associa-
tions of selected sociodemographic and clinical factors with the odds of having 
lymphedema awareness (adequate vs. inadequate). Th e median (range) of the 
lymphedema awareness score was 4 (0-7). Compared with patients <50 years 
of age, patients 70+ years of age at breast cancer diagnosis had lower odds of 
adequate lymphedema awareness (OR 0.25; 95 % CI 0.07, 0.89), while patients 
50-59 and 60-69 years had greater odds of adequate awareness although not 
statistically signifi cant (OR 2.05; 95 % CI 0.88, 4.78 and OR 1.55; 95 % CI 
0.60, 4.02, respectively; p for trend = 0.09). Higher educational level and greater 
health literacy were suggestive of adequate awareness yet were not signifi cant. 
Th ese results can help inform educational interventions to strengthen patient 
knowledge of lymphedema risk and risk reduction practices, particularly in an 
integrated health care delivery setting. With the growing population of breast 
cancer survivors, increasing patient awareness and education about lymphedema 
risk reduction and care after cancer diagnosis is warranted.
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